Pricing Log in Create free account

Aptevo Therapeutics Inc. (APVO) vs Calidi Biotherapeutics, Inc. (CLDI)

Aptevo Therapeutics Inc. and Calidi Biotherapeutics, Inc. are both Biotechnology companies. Aptevo Therapeutics Inc. and Calidi Biotherapeutics, Inc. are of similar size ($3.2M and $3.1M). Calidi Biotherapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Aptevo Therapeutics Inc. trades at 0.0×. Across the 10 metrics below, Aptevo Therapeutics Inc. leads on 8 and Calidi Biotherapeutics, Inc. on 2.

Valuation

Metric APVO CLDI Biotechnology median
P/E 0.00 n/m 8.50
P/S 0.15 n/m 9.71
P/B 0.32 0.38 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.17 0.07 0.64
EV/Sales (0.34) n/m 9.21
Earnings yield 100,773.33% (6,464.29%) (33.15%)
Free cash flow yield (1,315.16%) (1,500.29%) (25.50%)

Profitability

Metric APVO CLDI Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (446.89%) (900.56%) (56.36%)
Return on assets (186.29%) (283.36%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric APVO CLDI Biotechnology median
Revenue growth (TTM) 92.94% — 6.02%
EPS growth (last fiscal year) 99.72% 83.31% 30.26%
Revenue growth, 5-year CAGR (26.64%) — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric APVO CLDI Biotechnology median
Debt to equity 0.00 0.24 0.00
Current ratio 2.08 1.68 4.72
Net debt to EBITDA 0.83 0.26 0.96

Dividend

Metric APVO CLDI Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric APVO CLDI Biotechnology median
Market cap 3.08m 3.20m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack